文献速递细菌感染、耐药与抗菌药物医院感染防控

美国医院疑似脓毒症患者抗生素降阶梯治疗的流行病学与结局

Epidemiology and Outcomes of Antibiotic De-escalation in Patients With Suspected Sepsis in US Hospitals.
PubMed 文献 · Clin Infect Dis · 2025-01-01

该回顾性研究分析了2017-2021年美国236家医院中124577例疑似脓毒症成人患者,初始接受≥2天抗MRSA和抗假单胞菌抗生素但至第4天未发现耐药菌。降阶梯治疗发生率为29.5%,医院间差异大,与疾病严重程度低、培养阳性及MRSA鼻拭子阴性相关,并与急性肾损伤、ICU入住及住院死亡风险降低相关。

要点

  • 疑似脓毒症患者中抗生素降阶梯治疗发生率为29.5%,医院间差异大。
  • 降阶梯与急性肾损伤、第4天后ICU入住及住院死亡风险降低相关。
  • 降阶梯预测因素包括第3-4天病情较轻、非耐药菌培养阳性及MRSA鼻拭子阴性。

核心结论

  • 疑似脓毒症中抗生素降阶梯不常见、医院间差异大,与临床和微生物因素相关,并与急性肾损伤、ICU入住及住院死亡风险降低相关。

研究设计与样本

  • 回顾性分析2017-2021年美国236家医院收治的疑似脓毒症成人患者,定义为血培养送检、乳酸测量及静脉抗生素使用。
  • 纳入初始接受≥2天抗MRSA和抗假单胞菌抗生素、但至住院第4天未发现需这些药物的耐药菌的患者。
  • 降阶梯定义为第4天前停用抗MRSA和抗假单胞菌抗生素或换用更窄谱抗生素。
  • 使用82个医院和临床变量构建降阶梯倾向评分,将降阶梯与非降阶梯患者匹配后评估结局关联。

主要发现

  • 124577例患者中,36806例(29.5%)降阶梯:27177例(21.8%)窄谱化,9629例(7.7%)停用。
  • 医院间降阶梯率中位数29.4%,四分位距21.3%-38.0%。
  • 降阶梯的预测因素包括第3-4天病情较轻、非耐药菌培养阳性及MRSA鼻拭子阴性/未做。
  • 东北部和中西部的中型、大型及教学医院的降阶梯更常见。
  • 降阶梯与急性肾损伤调整后风险降低相关(OR 0.80;95%CI 0.76-0.84)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little is known about the frequency, hospital-level variation, predictors, and outcomes of antibiotic de-escalation in suspected sepsis. METHODS: We retrospectively analyzed adults admitted to 236 US hospitals from 2017-2021 with suspected sepsis (defined by blood culture draw, lactate measurement, and intravenous antibiotic administration) who were initially treated with ≥2 days of anti-methicillin-resistant Staphylococcus aureus (MRSA) and anti-pseudomonal antibiotics but had no resistant organisms that required these agents identified through hospital day 4. De-escalation was defined as stopping anti-MRSA and anti-pseudomonal antibiotics or switching to narrower antibiotics by day 4. We created a propensity score for de-escalation using 82 hospital and clinical variables; matched de-escalated to non-de-escalated patients; and assessed associations between de-escalation and outcomes. RESULTS: Among 124 577 patients, antibiotics were de-escalated in 36 806 (29.5%): narrowing in 27 177 (21.8%), cessation in 9629 (7.7%). De-escalation rates varied between hospitals (median, 29.4%; interquartile range, 21.3%-38.0%). Predictors of de-escalation included less severe disease on day 3-4, positive cultures for nonresistant organisms, and negative/absent MRSA nasal swabs. De-escalation was more common in medium, large, and teaching hospitals in the Northeast and Midwest. De-escalation was associated with lower adjusted risks for acute kidney injury (AKI) (odds ratio [OR], 0.80; 95% confidence interval [CI], .76-.84), intensive-care unit (ICU) admission after day 4 (OR, 0.59; 95% CI, .52-.66), and in-hospital mortality (OR, 0.92; 95% CI, .86-.996). CONCLUSIONS: Antibiotic de-escalation in suspected sepsis is infrequent, variable across hospitals, linked with clinical and microbiologic factors, and associated with lower risk for AKI, ICU admission, and in-hospital mortality.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Kam KQ, Chen T, Kadri SS, et al. Epidemiology and Outcomes of Antibiotic De-escalation in Patients With Suspected Sepsis in US Hospitals. Clin Infect Dis. 2025. PMID: 39657050. doi:10.1093/cid/ciae591

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。